Keywords: Neurography, Contrast Agents, MR Neurography, USPIO
Motivation: Ferumoxytol effectively suppresses vasculature in MR neurography, but the optimal dose is unknown.
Goal(s): To determine the optimal dose by weight and blood volume.
Approach: Thirty-two subjects were infused with varying Ferumoxytol doses (30 to 255 mg Fe) and underwent MR neurography at 3-Tesla; the vessel-to-muscle contrast ratio (CR) was measured.
Results: Logarithmic regression improved with weight-based and volume-based doses (R²=0.443 to 0.613) versus the absolute dose (R²=0.362 to 0.499). 1.75-1.92 mg Fe/kg or 26.9-29.5 mg Fe/L doses were required to obtain CR<0.2, demonstrating that the subject weight/blood volume should be considered to optimize Ferumoxytol-based vascular suppression.
Impact: Subject weight- or blood-volume-specific Ferumoxytol doses may provide effective vascular suppression for MR neurography evaluation of peripheral neuropathies like Parsonage Turner Syndrome (PTS), to reduce the dose and infusion time required.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords